• OPEN AN ACCOUNT
Indian Indices
Sensex
79,310.01 2,008.61
( 2.60%)
Global Indices
Nasdaq
53,347.89 1,540.17
(2.97%)
Dow Jones
7,717.41 127.49
(1.68%)
Hang Seng
60,935.13 -1,253.50
(-2.02%)
Nikkei 225
10,852.07 213.64
(2.01%)
Forex
USD-INR
94.73 -0.07
(-0.07%)
EUR-INR
105.99 -0.12
(-0.11%)
GBP-INR
127.06 -0.04
(-0.03%)
JPY-INR
0.60 0.00
(-0.31%)

EQUITY - MARKET SCREENER

Centuple Global Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
531099
INE396H01019
3.7787934
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
15
18.54
EPS(TTM)
Face Value()
Div & Yield %
2.26
10
0
 

bcl enterprises ltd
Sanofi India jumps after Nippon India MF adds stake
Jun 15,2026
According to exchange data, Nippon India Mutual Fund purchased 2.64 lakh shares, or 1.15% equity, of Sanofi India at Rs 3,150 per share through a bulk deal on 12 June 2026.

The shares were sold by HDFC Life Insurance Company, which offloaded 2.75 lakh shares, or 1.19% equity, at the same price.

As of the March 2026 quarter, Nippon India Small Cap Fund held an aggregate 3.79% stake in Sanofi India, while HDFC Life Insurance Company's Shareholders Solvency Margin Account owned 1.47% of the pharmaceutical company.

Sanofi India is engaged in the manufacture and marketing of pharmaceutical products and vaccines. On a standalone basis, Sanofi India's net profit declined 14.14% to Rs 102.60 crore while net sales declined 11.87% to Rs 472.30 crore in Q4 March 2026 over Q4 March 2025.